ToPCourT protocol: a phase II trial of Trilaciclib, Pembrolizumab, gemcitabine, and Carboplatin in locally advanced/unresectable or metastatic Triple-negative breast cancer
查看已审核书目、规范引用与获取指引。下载与积分规则登录后查看。
文献信息
题目
ToPCourT protocol: a phase II trial of Trilaciclib, Pembrolizumab, gemcitabine, and Carboplatin in locally advanced/unresectable or metastatic Triple-negative breast cancer
作者
Megan B. Sears-Smith, Ashley Matusz-Fisher, James T. Symanowski, Antoinette R. Tan
Scihuhuan